ProteoGenix

Custom development of assays and therapeutic antibodies

ProteoGenix is a leading antibody production company founded in 2003, based in Strasbourg, France. Their integrated solutions from gene to biotherapeutics & diagnostics make ProteoGenix the preferred partner of pharmaceutical & biotech companies for their custom assay development and therapeutic antibody discovery.

The company outstands in unique expertise in Phage Display technology based on unique proprietary Phage Display libraries with huge diversity; bypassing the need for the lengthy steps of animal immunization & subsequent library construction.

ProteoGenix offers unique and customized access to 6 areas of complementary services, structured around:

Antibody engineering (Humanization, Bi-specific, ADC, affinity maturation, molecule optimization)
Bioprocess development (IP free stable cell line development, fermentation and bioreactor production optimization)
Monoclonal and polyclonal antibody development (Hybridoma method and Phage Display)
Recombinant protein and antibody production (E. coli, B. subtilis, Yeast, Insect cells, Mammalian cells)
Gene synthesis
Peptide synthesis

Their R&D labs constantly influence the company's processes with outstanding innovations like XtenCHO™ (a cell line for transient expression exceeding ExpiCHO’s productivity performance), and have developed an extensive catalog of 200,000+ products.